Pfizer's Canadian Lipitor Patent Declared Invalid
A Canadian court has shot down Pfizer Inc.'s bid to block Ranbaxy Laboratories Ltd. from marketing a generic version of blockbuster drug Lipitor in Canada until 2010, ruling that a Pfizer...To view the full article, register now.
Already a subscriber? Click here to view full article